Shore Capital Reaffirms Buy Rating for ECO Animal Health Group (LON:EAH)

Shore Capital reissued their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note issued to investors on Monday, MarketBeat.com reports.

ECO Animal Health Group Trading Down 4.2 %

LON:EAH opened at GBX 58.35 ($0.75) on Monday. ECO Animal Health Group has a 52-week low of GBX 51 ($0.66) and a 52-week high of GBX 135 ($1.74). The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81. The stock has a fifty day simple moving average of GBX 60.48 and a 200-day simple moving average of GBX 72.17. The company has a market capitalization of £39.54 million, a PE ratio of 37.72 and a beta of -0.05.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.